Document Detail


Effects of low serum triglyceride on stroke mortality: a prospective follow-up study.
MedLine Citation:
PMID:  20627296     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Low serum triglyceride (TG) has been suggested as a predictor of mortality after cardiovascular disease. However, the relationship between the level of TGs and the outcome after stroke remains to be elucidated. We hypothesized that the influence of TG levels on post-stroke mortality varies according to stroke mechanism: cardioembolic (CE) vs. non-CE causes.
METHODS: We prospectively enrolled a consecutive series of patients with first-ever acute ischemic stroke for 5 years (n=1067), and followed them until the end of 2007 to obtain information on mortality and cause of death. We divided the level of TG into the quartiles, and classified the patients into CE (n=226) and non-CE stroke groups (n=841). The influence of TG level on mortality (all-cause death and vascular death) was examined by univariate and multivariate analyses using Cox regression.
RESULT: All-cause death and vascular death rates showed inverse relationships to the quartiles of TG levels in all patients (p<0.001, both) and also in non-CE stroke group (p<0.001, both), but not in CE stroke group (p=0.17 and p=0.37, respectively). In the Cox-regression analysis, compared with the highest quartile, the adjusted hazard ratio (HR) of the lowest quartile for all-cause death was 2.58 [95% confidence interval (CI), 1.38-4.82] and that for vascular death was 3.50 (95% CI, 1.39-8.82) in non-CE stroke group. These same associations, however, were not significant in CE stroke group.
CONCLUSION: Our results indicate that low serum TG is an independent predictor of mortality after ischemic stroke brought on by non-CE causes.
Authors:
Wi-Sun Ryu; Seung-Hoon Lee; Chi Kyung Kim; Beom Joon Kim; Byung-Woo Yoon
Related Documents :
20339266 - Mechanical clot disruption following intravenous recombinant tissue plasminogen activat...
9794266 - Hemodynamic instability following carotid endarterectomy does not affect early discharge.
18353116 - Stroke secondary prevention and blood pressure reduction: an observational study of the...
10942686 - Eversion carotid endarterectomy generates fewer microemboli than standard carotid endar...
12421116 - Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis.
9277026 - Protriptyline, chronic tension-type headaches, and weight loss in women.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-11
Journal Detail:
Title:  Atherosclerosis     Volume:  212     ISSN:  1879-1484     ISO Abbreviation:  Atherosclerosis     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-03     Completed Date:  2010-12-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0242543     Medline TA:  Atherosclerosis     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  299-304     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Clinical Research Center for Stroke, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Biological Markers / blood
Brain Ischemia / blood*,  etiology,  mortality*
Cause of Death
Chi-Square Distribution
Down-Regulation
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Prognosis
Proportional Hazards Models
Prospective Studies
Republic of Korea / epidemiology
Risk Assessment
Risk Factors
Stroke / blood*,  etiology,  mortality*
Time Factors
Triglycerides / blood*
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Triglycerides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atheroscle...
Next Document:  Caustic ingestion as a manifestation of Fabricated and Induced Illness (Munchausen Syndrome by Proxy...